{"DataElement":{"publicId":"2774893","version":"1","preferredName":"Laboratory Procedure Creatinine Upper Limit of Normal Outcome Ind-2","preferredDefinition":"the yes/no indicator whether a medical procedure was performed that involves testing a sample of blood for creatinine, the breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function for which the result is related by the top value of the range of statistical characteristics.","longName":"LP_CREAT_ULN_OT_IND2","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2774891","version":"1","preferredName":"Laboratory Procedure Creatinine Upper Limit of Normal Outcome","preferredDefinition":"information related to the medical procedure that involves testing a sample of blood for creatinine, the breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function for which the result is related by the top value of the range of statistical characteristics.","longName":"LAB_CREATIN_ULN_RSLT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2774889","version":"1","preferredName":"Creatinine Upper Limit of Normal Outcome","preferredDefinition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.(NCI):The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C399:C25706:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Creatinine","conceptCode":"C399","definition":"The breakdown product of creatine, a constituent of muscle tissue, that is excreted by the kidney and whose serum level is used to evaluate kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Upper Limit of Normal","conceptCode":"C25706","definition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54BCB9FF-41A9-674E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-18","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-08-18","modifiedBy":"ONEDATA","dateModified":"2008-08-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54BCB9FF-41BA-674E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-18","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-08-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"},{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000172","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104913","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104888","version":"1","longName":"GOG-0209","context":"NRG"},{"publicId":"4104896","version":"1","longName":"GOG-0249","context":"NRG"},{"publicId":"4104881","version":"1","longName":"GOG-0227G","context":"NRG"},{"publicId":"4104893","version":"1","longName":"GOG-0230D","context":"NRG"},{"publicId":"4104889","version":"1","longName":"GOG-0229K","context":"NRG"},{"publicId":"4104883","version":"1","longName":"GOG-0240","context":"NRG"},{"publicId":"4104899","version":"1","longName":"GOG-0261","context":"NRG"},{"publicId":"4104886","version":"1","longName":"GOG-0265","context":"NRG"},{"publicId":"4104940","version":"1","longName":"GOG-0268","context":"NRG"},{"publicId":"4104915","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"10000592","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"10000591","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"4104917","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000174","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000175","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000164","version":"1","longName":"GOG-0273","context":"NRG"},{"publicId":"10000165","version":"1","longName":"GOG-0273","context":"NRG"},{"publicId":"4104919","version":"1","longName":"GOG-0273","context":"NRG"},{"publicId":"4104885","version":"1","longName":"GOG-0263","context":"NRG"}]}],"AlternateNames":[{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"LP_CREAT_ULN_OT_IND2","type":"USED_BY","context":"NRG"},{"name":"LP_CREAT_ULN_OT_IND2","type":"USED_BY","context":"Alliance"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Is the Serum Creatinine less","type":"Preferred Question Text","description":"Is the Serum Creatinine less than or equal to ULN","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Is the creatinine less than or equal to 1.5 X ULN","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Is creatinine <=1.5 x institutional upper limit of normal, grade 1 per CTCAE Version 4.0?","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Is Serum Creatinine less than or equal to 1.5 X ULN","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Is creatinine less than or equal to ULN?","url":null,"context":"CTEP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Serum Creatinine in normal range:","url":null,"context":"COG"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Is serum creatinine <= 1.5 mg/dL?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Is the patient's creatinine less than or equal to 1.5 mg/dL?","url":null,"context":"NRG"},{"name":"CRF Text 5","type":"Alternate Question Text","description":"Is the patient's serum creatinine between 1.5 and 1.9 mg/dL within 14 days prior to randomization?","url":null,"context":"CTEP"},{"name":"NRG_eCRF_Text_2","type":"Alternate Question Text","description":"Is creatinine less than or equal to 1.5 x institutional/laboratory upper limit of normal (ULN)?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_3","type":"Alternate Question Text","description":"Is the patient's creatinine less than or equal to 1.5 times the laboratory upper limit of normal (ULN) 14 days prior to enrollment?","url":null,"context":"NRG"},{"name":"CRF Text 6","type":"Alternate Question Text","description":"Is creatinine less than or equal to 1.5 x institutional/laboratory (ULN) or creatinine clearance greater than 50mL/min/1.73m^2?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_5","type":"Alternate Question Text","description":"Is serum creatinine less than or equal to 1.5 x ULN for the lab within 28 days before randomization?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_6","type":"Alternate Question Text","description":"Is creatinine less than or equal to institutional/laboratory upper limit of normal (ULN) or creatinine clearance (CrCL) or estimated Glomerular filtration rate (GFR)  of greater than or equal to 60 mL/min estimated using either the Cockcroft-Gault equation, the Modification of Diet in Renal Disease Study, or as reported in the comprehensive metabolic panel/basic metabolic panel (eGFR) within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_4","type":"Alternate Question Text","description":"Is serum creatinine less than or equal to 1.5 x ULN for the lab within 28 days before study entry?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_7","type":"Alternate Question Text","description":"Is creatinine less than or equal to 1.5 x institutional/laboratory upper limit of normal (ULN) within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_9","type":"Alternate Question Text","description":"Is creatinine less than or equal to institutional/laboratory upper limit of normal (ULN) or creatinine clearance greater than or equal to 50 mL/min/1.73 m2 for patients with levels above institutional normal?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_8","type":"Alternate Question Text","description":"Is creatinine clearance (CrCL) greater than or equal to 51 mL/min (estimated using Cockcroft-Gault equation) within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"CRF TEXT 1","type":"Alternate Question Text","description":"Is creatinine less than or equal to 1.5 x institutional/laboratory upper limit of normal (ULN) or estimated Glomerular filtration rate (eGFR) of greater than or equal to 50 mL/min using either the Cockcroft-Gault equation, the Modification of Diet in Renal Disease Study, or as reported in the comprehensive metabolic panel/basic metabolic panel (eGFR)?","url":null,"context":"NRG"},{"name":"CRF Text 1","type":"Alternate Question Text","description":"Is creatinine less than or equal to 1.5 x institutional/laboratory upper limit of normal (ULN) or estimated Glomerular filtration rate (eGFR) of greater than or equal to 50 mL/min using either the Cockcroft-Gault equation, the Modification of Diet in Renal Disease Study, or as reported in the comprehensive metabolic panel/basic metabolic panel (eGFR) within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_10","type":"Alternate Question Text","description":"Is GFR greater than or equal to 60mL/min/1.73m2 measured using Cockcroft-Gault equation or the estimated glomerular filtration rate from the Modification of Diet in Renal Disease Study within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Is serum creatinine less than or equal to 1.5 x ULN or measured or calculated creatinine clearance greater than or equal to 50 mL/min using the Cockcroft-Gault formula for patients with creatinine levels greater than 1.5 x ULN for the lab within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 2","type":"Alternate Question Text","description":"Is serum creatinine less than or equal to 1.5 x ULN or measured or calculated creatinine clearance greater than or equal to 50 mL/min using the Cockcroft-Gault formula for patients with creatinine levels greater than 1.5 x ULN for the lab within 14 days prior to second registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 3","type":"Alternate Question Text","description":"Is measured or calculated creatinine clearance greater than or equal to 30 mL/min within 14 days prior to registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 4","type":"Alternate Question Text","description":"Is measured or calculated creatinine clearance greater than or equal to 30 mL/min within 14 days prior to second registration?","url":null,"context":"NRG"},{"name":"NRG CRF Text 5","type":"Alternate Question Text","description":"Is calculated creatinine clearance (CrCL) of greater than or equal to 50 mL/min by the Cockcroft-Gault formula?","url":null,"context":"NRG"},{"name":"NRG CRF Text 6","type":"Alternate Question Text","description":"Is creatinine clearance (CrCL) greater than or equal to 30 mL/min by the Cockcroft-Gault formula?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_11","type":"Alternate Question Text","description":"Is serum creatinine less than or equal to 1.5 x ULN for the lab within 28 days before Step 1/Study entry?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_13","type":"Alternate Question Text","description":"Is creatinine clearance (CrCL) of greater than or equal to 30 mL/min by the Cockcroft-Gault formula?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_14","type":"Alternate Question Text","description":"Is creatinine less than or equal to the institutional upper limit of normal (ULN) or calculated creatinine clearance (CrCL) greater than or equal to 50 mL/min by the Cockcroft-Gault formula?","url":null,"context":"NRG"}],"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"54BCC565-383A-6A00-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-08-18","endDate":null,"createdBy":"ALAIS","dateCreated":"2008-08-18","modifiedBy":"TYRRELLM","dateModified":"2023-12-20","changeDescription":"Replaced VD Assessments Ind-2 2018320v1.0 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"12.20.2023 Added AQT per request ticket CADSR0003202_mmt\r\n9.28.2023 Added AQT per request CADSR0002895_mmt\r\n2022.11.15 AQT added for ticket request CADSR0001687. ak","unresolvedIssues":null,"deletedIndicator":"No"}}